Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study.
Eur Stroke J
; 9(3): 696-703, 2024 Sep.
Article
in En
| MEDLINE
| ID: mdl-38567789
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vitamin K
/
Ischemic Attack, Transient
/
Factor Xa Inhibitors
/
Ischemic Stroke
/
Hemorrhage
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur Stroke J
Year:
2024
Document type:
Article
Affiliation country:
Alemania
Country of publication:
Reino Unido